Cidara Therapeutics Q3 2023 Financial Results Overview
Tuesday, 13 August 2024, 21:36
Cidara Therapeutics Q3 2023 Financial Overview
Cidara Therapeutics has recently announced its financial results for the third quarter of 2023. The company reported a GAAP EPS of -$20.65, indicating significant net losses. Alongside this, revenue stood at $0.3M for the quarter.
Financial Highlights
- Loss per Share: -$20.65
- Revenue: $0.3 million
These figures highlight the ongoing financial challenges faced by Cidara Therapeutics, raising concerns about the company's path forward. Investors and analysts alike will need to evaluate potential strategies for recovery and growth moving forward.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.